Following the script: How drug reps make friends and influence doctors

PLoS Medicine

Volumn 4, Issue 4, 2007, Pages 621-625

  Fugh Berman, Adriane ^a   Ahari, Shahram ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSUMER ADVOCACY; DRUG COST; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HUMAN; MEDICAL SPECIALIST; PHYSICIAN; PRESCRIPTION; REVIEW; ECONOMICS; FRIEND; LEADERSHIP; MARKETING; METHODOLOGY;

DRUG INDUSTRY; FRIENDS; HUMANS; LEADERSHIP; MARKETING; PHYSICIANS;

EID: 34247508586     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040150     Document Type: Review

References (26)

1. Elliott C (2006) The drug pushers. Atlantic Monthly (April): 2-13.
2. Rosenthal MB, Berndt ER, Donohue JM, Epstein AM, Frank RG (2003) Demand effects of recent changes in prescription drug promotion. Henry J Kaiser Family Foundation. Available: http://www.kff.org/rxdrugs/6085-index.cfm. Accessed 23 March 2007.
3. Niles S (2005) Sales force effectiveness (the third in a series of articles that examine problems and solutions of detailing to physicians). Med Ad News 24: 1.
4. Reidy J (2005) Hard sell: The evolution of a Viagra salesman. Kansas City: Andrews McMeel Publishing. 210 p.
5. Steinbrook R (2006) For sale: Physicians' prescribing data. New Engl J Med 354: 2745-2747.
6. Merck (2002) Basic training participant guide. Available: http://oversight.house.gov/features/vioxx/documents.asp. Accessed 23 March 2007.
7. Nickum C, Kelly T (2005) Missing the mark(et). Pharmaceutical Executive. Available: http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id= 177968. Accessed 23 March 2007.
8. Medical Marketing Services (2007) American Medical Association list. Available: http://www.mmslists.com/category_drilldown.asp?nav= category&headingID=1&itemID=1. Accessed 23 March 2007.
9. Hogg JJ (2006) Marketing to professionals: Diagnosing MD behavior. Pharmaceutical Executive: 168. Available: http://www.pharmexec.com/pharmexec/ article/articleDetail.jsp?id=162039. Accessed 23 March 2007.
10. Hradecky G (2004) Breaking point. Pharmaceutical Representative. Available: http://www.pharmrep.com/pharmrep/article/articleDetail.jsp?id=102324. Accessed 23 March 2007.
11. Brand R, Kumar P (2003) Detailing gets personal: Integrated segmentation may be pharma's key to "repersonalizing" the selling process. Pharmaceutical Executive. Available: http://www.pharmexec.com/pharmexec/article/ articleDetail.jsp?id=64071. Accessed 23 March 2007.
12. Alonso J, Menzies D (2006) Just what the doctor ordered. Pharmaceutical Executive: 14-16. Available: http://www.pharmexec.com/pharmexec/article/ articleDetail.jsp?id=323314. Accessed 23 March 2007.
13. Remus PC (2006 November 10) First-in-the-nation law pits NH against drug industry. New Hampshire Business Review. Available: http://www.nh.com/apps/pbcs. dll/article?AID=/20061110/BUSINESSREVIEW05/61108030/-1/BUSINESSREVIEW. Accessed 23 March 2007.
14. Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C,et al. (2000) A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med 15: 478-483.
15. Groves KEM, Sketris I, Tett SE (2003) Prescription drug samples - Does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther 28: 259-271.
16. Sadek H, Henderson Z (2004) It's all in the details: Delivering the right information to the right rep at the right time can greatly increase sales force effectiveness. Pharmaceutical Executive. Available: http://www.pharmexec.com/ pharmexec/article/articleDetail.jsp?id=129291. Accessed 23 March 2007.
17. Adair RF, Holmgren LR (2005) Do drug samples influence resident prescribing behavior? A randomized controlled trial. Am J Med 118: 881-884.
18. United States Government Accountability Office (2006) Prescription drugs: Price trends for frequently used brand and generic drugs from 2000 through 2004. Available: http://www.gao.gov/new.items/d05779.pdf. Accessed 23 March 2007.
19. Kaiser Family Foundation (2006) Prescription drug trends. Available: http://www.kff.org/rxdrugs/3057.cfm. Accessed 23 March 2007.
20. Marshall PC (2005) Rep tide: Pulling back in magnitude, pushing forward efficiency: Recent talk of pharma companies restructuring or even paring back their sales forces is the first acknowledgement that efficiency, and not noise, is the key to effective detailing. Med Market Media 40: 96.
21. Goldberg M, Davenport B, Mortellito T (2004) PE's annual sales and marketing employment survey: The big squeeze. Pharmaceutical Executive 24: 40-45. Available: http://www.pharmexec.com/pharmexec/article/articleDetail.jsp? id=80921. Accessed 23 March 2007.
22. Millenson ML (2003) Getting doctors to say yes to drugs: The cost and quality of impact of drug company marketing to physicians. Blue Cross Blue Shield Association. Available: http://www.bcbs.com/betterknowledge/cost/getting- doctors-to-say-yes.html. Accessed 23 March 2007.
23. Kaiser Family Foundation (2006) National survey of physicians. Available: http://www.kff.org/rxdrugs/upload/3057-05.pdf. Accessed 23 March 2007.
24. Goldberg M, Davenport B (2005) In sales we trust. Pharmaceutical Executive . Available: http://www.pharmexec.com/pharmexec/article/articleDetail. jsp?id=146596. Accessed 23 March 2007.
25. [No authors listed] (2004) Hard sell: As expanding the sales force becomes a less attractive option, pharmaceutical companies are reevaluating their sales strategies. Med Ad News 23: 1.
26. Oldani MJ (2004) Thick prescriptions: Toward an interpretation of pharmaceutical sales practices. Med Anthropol Q 18: 328-356.